Share

Efficacy And Safety Of Oral Phentolamine (Vasomax) For The Treatment Of MinimalErectile Dysfunction

Researchers conducted two multicenter trials with a new drug for minimal erectile dysfunction. The first phase was designed as a placebo-controlled, parallel group, double-blind study involving randomized doses of 40 mg or 80 mg of either oral phentolamine or placebo. In the 40 mg group, out of 152 men, 56 (37%) responded and 96 (63%) did not. With the 80 mg dose, out of 159 men, 72 (45%) responded and 87 (55%) did not. Out of 148 patients on placebo, 24 (16%) responded.

A responder was considered any man whose condition improved by one clinical dysfunction class and who had, at endpoint, mild to moderate erectile dysfunction. The second phase was a placebo-controlled, crossover design of fixed dose 40 mg oral phentolamine versus placebo. Out of 148 patients who took 40 mg of oral phentolamine, 50 (34%) responded. Out of 145 patients on placebo, 30 (21%) responded. Although they involved less than 10% of the men, side effects to the 40 mg dose included headache, facial flushing, and nasal consumptio n. The investigators concluded that the 40 mg oral phentolamine dose is a safe and effective oral medication for the treatment of mild erectile dysfunction.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.